INTERNATIONAL PATENT: 4CELL THERAPIES SPOŁKA AKCYJNA FILES APPLICATION FOR "MULTISPECIFIC 2A3 ANTIBODY, NUCLEIC ACID MOLECULE ENCODING THE ANTIBODY, VECTOR COMPRISING THE NUCLEIC ACID MOLECULE, CONSTRUCT COMPRISING A CAR WITH THE ANTIBODY AND THEIR USE IN CAR-T CELL THERAPY FOR TREATING SOLID TUMORS"

GENEVA, April 29 -- 4CELL THERAPIES SPOŁKA AKCYJNA (Bojkowska 59C44-100 Gliwice) filed a patent application (PCT/PL2025/050077) for "MULTISPECIFIC 2A3 ANTIBODY, NUCLEIC ACID MOLECULE ENCODING THE ANTIBODY, VECTOR COMPRISING THE NUCLEIC ACID MOLECULE, CONSTRUCT COMPRISING A CAR WITH THE ANTIBODY, AND THEIR USE IN CAR-T CELL THERAPY FOR TREATING SOLID TUMORS" on Oct 13, 2025. With publication no. WO/2026/084605, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JANCEWICZ, Iga (02-496 Warszawa), WIŚNIEWSKI, Paweł...